4Th International Conference On Innovations And Advances In Cancer Research And Treatment

2026-05-25 11:00:09

(MENAFN- PR Urgent) > Scitechseries proudly presents the esteemed the 4th International Conference on Innovations and Advances in Cancer Research and Treatment - Cancer 2026, scheduled in Tokyo, Japan during October 08-09, 2026.

This conference will explore on the theme " Empowering Global Collaboration in Cancer Care."

Cancer 2026 ignites breakthroughs and ignites collaborations, uniting pioneers across disciplines. From researchers and oncologists to geneticists and engineers, the conference tackles critical challenges in cancer research and treatment, aligning with the global fight for a cure. Cutting-edge therapies, precision medicine advancements, and innovative technologies will be explored, paving the way for comprehensive solutions against this complex disease.

This international gathering features impactful Keynote presentations, insightful Oral sessions, interactive Poster exhibitions, and dynamic panel discussions across over twenty thematic tracks. Renowned experts will unveil their latest discoveries, sparking debates, fostering collaborations, and propelling the field towards a future free from cancer.

Conference Proceedings Publication Notice:

The proceedings of the 4th International Conference on Innovations and Advances in Cancer Research and Treatment will be published in the Archives in Oncology Research (e-ISSN: 3068-5273), with a DOI assignment. This ensures that all accepted work is formally documented, peer-reviewed, and indexed in a respected international journal-enhancing visibility, credibility, and academic recognition.

Be a part of the revolution at Cancer 2026!

MENAFN25052026003734003177ID1111166217

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.